Pfizer announced cash acquisition of Seagen, a cancer specialist biotech for $43 Bn - largest pharma M&A in 3 years. CEO Albert Bourla says 1-i

Pfizer announced cash acquisition of Seagen, a cancer specialist biotech for $43 Bn - largest pharma M&A in 3 years. CEO Albert Bourla says 1-i